| Popis: |
IntroductionOn March 10, the first case of coronavirus disease 2019 (COVID-19) was reported in Turkey; in the meantime, over 95 million confirmed cases with more than 2 million deaths have been reported worldwide. Case PresentationAfter the identification of first COVID-19 (+) patient, our center conducted the management of selection and treatment of candidates and continued to perform cardiac transplantations. We herein present two cases after determination of patient zero in Turkey in order to highlight clinical implications by describing our clinic principle in the ethical knowledge of ISHLT COVID-19 Task force statement regarding heart transplantation (HTx).ConclusionsCOVID-19 creates a challenge on donor selection and post-transplant management and immunosuppressive therapy. And, a question arises about continuing HTx due to risk of immunosuppressive therapy, as well as exposure during hospitalization. |
